NCT00514475
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Arne Kolstad Oslo, Norway
Clinical trial condition
Mantle Cell Lymphoma
Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
251 public trials
59 recruiting studies
Mantle Cell Lymphoma trial results
NCT01263899
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +11 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Weill Medical College of Cornell New York, United States
- University of Rochester James P. Wilmot Cancer Center Rochester, New York, United States
- MD Anderson Cancer Canter Houston, Texas, United States
NCT00505232
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital Marques de Valdecilla Santander, Cantabria, Spain
- Hospital del Mar Barcelona, Catalonia, Spain
- Hospital Clínico de Santiago de Compostela Santiago de Compostela, Galica, Spain
NCT00275431
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large Cell Lymphoma, +24 more
- Locations
-
- Birmingham, Alabama, United States
- San Diego, California, United States
- Atlanta, Georgia, United States
- Chicago, Illinois, United States
NCT00612183
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Kashiwa, Chiba, Japan
- Fukuoka, Japan
- Sapporo, Hokkaido, Japan
NCT00285389
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Regional university hospital Besançon, France
- Regional university hospital Rennes, France
- REgional Hospital Tours, France
NCT00063713
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Alta Bates Medical Center Berkeley, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Loma Linda Cancer Research Institute Loma Linda, California, United States
NCT00090090
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
- Locations
-
- Alta Bates Cancer Center Berkeley, California, United States
- Providence Saint Joseph Medical Center Burbank, California, United States
- USC Norris Cancer Center Los Angeles, California, United States
- Tower Hematology Oncology Medical Group Los Angeles, California, United States
NCT00022945
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Rush-Presbyterian-St. Lukes Medical Center Chicago, Illinois, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Active, Not Recruiting
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
- Locations
-
- Alaska Oncology and Hematology ( Site 0037) Anchorage, Alaska, United States
- Banner MD Anderson Cancer Center ( Site 0040) Gilbert, Arizona, United States
- Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036) Phoenix, Arizona, United States
- University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008) Aurora, Colorado, United States